Timolol hemihydrate: A new formulation of timolol for the treatment of glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 2, 1996, Pages 225-237

  Stewart, William C ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; TIMOLOL; TIMOLOL MALEATE;

CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0029929054     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.225     Document Type: Review

References (30)

1. Stewart, W.C. Clinical Practice of Glaucoma. Slack, Inc., Thorofare, NJ, 1990, p. 251-261.
2. Ball, S.F. and Schneider, E. Cost of β-adrenergic receptor blocking agents for ocular hypertension. Arch Ophthalmol 110:654-657, 1992.
3. Keates, E.U. and Stone, R. The effect of δ-timolol on intraocular pressure in patients with, ocular hypertension. Am J Ophthalmol 98:73-78, 1984.
4. Liu, J.H.K., Bartels, S.P., and Neufeld, A.H. Effects of 1- and d-timolol on cyclic AMP synthesis and intraocular pressure in water-loaded, albino and pigmented rabbits. Invest Ophthalmol Vis Sci 24:1276-1282. 1983.
5. Verani, R.R., Brewer, E.D., Ince, A., Gibson, J., and Bulger, R.E. Proximal tubular necrosis associated with maleic acid administration to the rat. Lab Invest 46:79-88, 1982.
6. Heskel, N.S., Samour, C.M., and Storrs, F.J. Allergic contact dermatitis from dodecyl maleamic acid in Curad adhesive plastic bandages. J Am Acad Dermatol 7:747-751, 1982.
7. Grant, W.M. Toxicology of the Eye, 2nd ed. Charles C. Thomas, Springfield, IL, 1974, p. 640-641.
8. Winter, C.A. and Tullius, E.J. The irritating effects of maleic acid and of maleic anhydride upon the eyes of rabbits. Am J Ophthalmol 33:387-388, 1950.
9. Zimmerman, T.J., Harbin, R., Pett, M., and Kaufman, H.E. Timolol and facility of outflow. Invest Ophthalmol Vis Sci 16:623-624, 1977.
10. Sonntag, J.R., Brindley, G.O., and Shields, M.B. Effect of timolol therapy on outflow facility. Invest Ophthalmol Vis Sci 17:292-296, 1978.
11. Coakes, R.L. and Brubaker, R.F. The mechanism of timolol in lowering intraocular pressure. In the normal eye. Arch Ophthalmol 96:2045-2048, 1978.
12. Yablonski, M.E., Zimmerman, T.J., Waltman, S.R., and Becker, B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 27:135-142, 1978
13. Miichi, H. and Nagataki, S. Effects of pilocarpine, salbutamol, and timolol on aqueous humor formation hi cynomolgus monkeys. Invest Ophthalmol Vis Sci 24:1269-1275, 1983.
14. Araië, M. and Takase, M. Effects of various drugs on aqueous humor dynamics in man. Jpn J Ophthalmol 25:91-111, 1981.
15. Brubaker, R.F. The physiology of aqueous humor formation. In Glaucoma: Applied Pharmacology in Medical Treatment, Drance, S.M. and Neufeld, A.H., eds. Grune & Stratton, Inc., New York, 1984, p. 35-70.
16. Weinreb, R.N., Ritch, R., and Kushner, F.H. Effect of adding betaxolol to dipivefrin therapy. Am J Ophthalmol 101:196-198, 1986.
17. Tsoy, E. A., Meekins, B.B., and Shields, M.B. Comparison of two treatment schedules for combined timolol and dipivefrin therapy. Am J Ophthalmol 102:320-324, 1986.
18. Neufeld, A.H. Experimental studies on the mechanism of action of timolol. Surv Ophthalmol 23:363-370. 1979.
19. Obstbaum, S.A., Galin, M.A., and Katz, I.M. Timolol: effect on intraocular pressure in chronic open-angle glaucoma. Ann Ophthalmol 10:1347-1351, 1978.
20. Lin, L.-L., Galin, M.A., Obstbaum, S.A., and Katz, I. Longterm timolol therapy. Surv Ophthalmol 23:377-380, 1979.
21. Bill, A. Effects of norepinephrine, isoproterenol and sympathetic Stimulation on aqueous humour dynamics in vervet monkeys. Exp Eye Res 10:31-46, 1970.
22. Alvan, G., Calissendorff, B., Seideman, P., Widmark, K., and Widmark, G. Absorption of ocular timolol. Clin Pharmacokin 5:95-100. 1980.
23. Passo, M.S., Palmer, E.A., and van Buskirk, E.M. Plasma timolol in glaucoma patients. Ophthalmology 91:1361-1363. 1984.
24. Zimmerman, T.J., Kooner, K.S., Kandarakis, A.S., and Ziegler, L.P. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 102:551-553, 1984.
25. Kaila, T., Salminen, L., and Huupponen, R. Systemic absorption of topically applied ocular timolol. J Ocul Pharmacol 1:79-83, 1985.
26. Marén, N. and Calissendorff, B.M. Timolol in aqueous humour after topical administration. A pilot study. Acta Ophthalmol 63:415-417. 1985.
27. Blanksma, L.J. Concentration of timolol in aqueous humour. Doc Ophthalmol 78:255-258, 1991.
28. Zimmennan, T.J. and Boger, W.P. The beta-adrenergic blocking agents and the treatment of glaucoma. Surv Ophthalmol 23:347-362, 1979.
29. Dollery, C., ed. Therapeutic Drugs. Churchill Livingstone, Edinburgh, 1991, p. T77-80.
30. Goethalsm,M. Ten-year follow-up of timolol-treated open-angle glaucoma (summary). Surv Ophthalmol 33(suppl):463-464, 1989.